Free tool
FAERS Monitor: Keppra Xr
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022285 or its brand name (Keppra Xr, Levetiracetam). Reports on generic versions are filed under their own applications.
Reports
135,017
Serious
111,948
83% of reports
Hospitalization
49,995
Death reported
12,113
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- seizure16,227
- drug ineffective12,556
- off label use9,747
- fatigue5,664
- somnolence4,247
- epilepsy4,201
- convulsion4,079
- maternal exposure during pregnancy3,821
- fall3,812
- headache3,770
- nausea3,654
- dizziness3,638
- drug interaction3,513
- diarrhoea3,306
- death3,286
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 515 |
| 2005 | 758 |
| 2006 | 908 |
| 2007 | 1,182 |
| 2008 | 1,356 |
| 2009 | 2,211 |
| 2010 | 2,463 |
| 2011 | 3,071 |
| 2012 | 4,029 |
| 2013 | 4,131 |
| 2014 | 4,698 |
| 2015 | 6,500 |
| 2016 | 8,419 |
| 2017 | 7,673 |
| 2018 | 10,372 |
| 2019 | 12,026 |
| 2020 | 9,949 |
| 2021 | 10,133 |
| 2022 | 8,974 |
| 2023 | 9,610 |
| 2024 | 9,964 |
| 2025 | 8,933 |
| 2026 | 7,138 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,919,142 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| seizureSignal | 16,227 | 25.3 | 24.9 | 327,276 |
| epilepsySignal | 4,201 | 24.7 | 23.9 | 82,345 |
| convulsionSignal | 4,079 | 11.9 | 11.5 | 37,869 |
| maternal exposure during pregnancySignal | 3,821 | 6.9 | 6.7 | 18,642 |
| drug interactionSignal | 3,513 | 3.5 | 3.4 | 6,194 |
| somnolenceSignal | 4,247 | 3.3 | 3.2 | 6,860 |
| fall | 3,812 | 1.8 | 1.7 | 1,343 |
| off label use | 9,747 | 1.7 | 1.7 | 3,180 |
| drug ineffective | 12,556 | 1.5 | 1.5 | 2,129 |
| dizziness | 3,638 | 1.1 | 1.1 | 61 |
| fatigue | 5,664 | 1.1 | 1.1 | 93 |
| headache | 3,770 | 0.9 | 0.9 | 17 |
| diarrhoea | 3,306 | 0.8 | 0.8 | 176 |
| nausea | 3,654 | 0.7 | 0.7 | 419 |
| death | 3,286 | 0.6 | 0.6 | 955 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.